Lenalidomide improves survival in previously treated patients with multiple myeloma

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2006年 / 20卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] POMALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PREVIOUSLY TREATED WITH LENALIDOMIDE
    Gomez, Hernando Marta
    Gironella, Merce
    Abella, Eugenia
    Cabezudo, Elena
    Motllo, Cristina
    Garcia, Antoni
    Sarra, Josep
    Mostacedo, Silvia
    Granell, Miquel
    Rosinol, Laura
    HAEMATOLOGICA, 2020, 105 : 13 - 14
  • [2] Continuous lenalidomide improves overall survival in multiple myeloma
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (06) : 309 - 309
  • [3] Efficacy of Lenalidomide in Patients with Multiple Myeloma Previously Treated by Melphalan-Prednisone and Thalidomide
    Michel, Jessica
    Revuz, Sabine
    Tardy, Stephanie
    Fouquet, Guillemette
    Roussel, Murielle
    Balasanu, Oana
    Bologna, Serge
    Bonmati, Caroline
    Perrot, Aurore
    Ranta, Dana
    Feugier, Pierre
    Attal, Michel
    Leleu, Xavier
    Facon, Thierry
    Hulin, Cyrille
    BLOOD, 2012, 120 (21)
  • [4] ECONOMIC EVALUATION OF LENALIDOMIDE IN THE MANAGEMENT OF PREVIOUSLY TREATED MULTIPLE MYELOMA (PTMM) PATIENTS IN GREECE
    Fragoulakis, V
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2012, 15 (04) : A104 - A105
  • [5] Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    Micallef, I. N. M.
    Ho, A. D.
    Klein, L. M.
    Marulkar, S.
    Gandhi, P. J.
    McSweeney, P. A.
    BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 350 - 355
  • [6] Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    I N M Micallef
    A D Ho
    L M Klein
    S Marulkar
    P J Gandhi
    P A McSweeney
    Bone Marrow Transplantation, 2011, 46 : 350 - 355
  • [7] Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma
    Takakuwa, Teruhito
    Ohta, Kensuke
    Nakatani, Eiji
    Ito, Tomoki
    Kaneko, Hitomi
    Fuchida, Shin-Ichi
    Shimura, Yuji
    Yagi, Hideo
    Shibayama, Hirohiko
    Kanda, Junya
    Uchiyama, Hitoji
    Kosugi, Satoru
    Tanaka, Hirokazu
    Kawata, Eri
    Uoshima, Nobuhiko
    Ishikawa, Jun
    Shibano, Masaru
    Karasuno, Takahiro
    Shindo, Maki
    Shimizu, Yoshifumi
    Imada, Kazunori
    Kanakura, Yuzuru
    Kuroda, Junya
    Hino, Masayuki
    Nomura, Shosaku
    Takaori-Kondo, Akifumi
    Shimazaki, Chihiro
    Matsumura, Itaru
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (03) : 349 - 357
  • [8] Erratum: Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    I N M Micallef
    A D Ho
    L M Klein
    S Marulkar
    P J Gandhi
    G Calandra
    P A McSweeney
    Bone Marrow Transplantation, 2011, 46 : 1398 - 1398
  • [9] Successful retreatment with lenalidomide for relapsed and refractory multiple myeloma previously treated with bortezomib, lenalidomide and pomalidomide
    Oka, Satoko
    Ono, Kazuo
    Nohgawa, Masaharu
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (06) : 914 - 917
  • [10] Bendamustine in advanced multiple myeloma previously treated with bortezomid and lenalidomide containing regimen
    Lehenbauer-Dehm, S.
    Alex, M.
    Pecher, G.
    Blau, I
    Eucker, J.
    Possinger, K.
    Scholz, C.
    ONKOLOGIE, 2012, 35 : 145 - 146
12345